Drug Trial Radar · NCT07581210
Efficacy and Safety of QD202 in Participants With Acute Ischemic Stroke Undergoing Thrombolysis Excluding Endovascular Thrombectomy
Last checked: Nov 19, 2026Latest source record: May 12, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Recruiting
Enrollment
120
Planned (sponsor's estimate)
Start
Oct 14, 2025
Primary completion
Aug 2026
Study completion Dec 2026
Sponsor
- Lead sponsor
- Shanghai QuietD Biotechnology Co., Ltd.Industry
- Sponsor type
- Industry
- First posted
- May 12, 2026
Design
- Study type
- Interventional
- Phase
- Phase 2
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Triple (participant, care provider, investigator)
- Primary purpose
- Treatment
- FDA-regulated drug
- No
- Who can join
- All sexes, from 18 years, up to 85 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
This is a randomized, double-blinded, placebo-controlled study investigating the safety and efficacy of QD202 injection in patients with acute ischemic stroke undergoing thrombolysis excluding endovascular thrombectomy. Up to 120 male and female patients with acute ischemic stroke undergoing thrombolysis excluding endovascular thrombectomy will be dosed with QD202 injection or placebo as a 60 minute intravenous infusion after completion of the thrombolysis procedure on Day 1-5 of the study period. Subjects will undergo interim procedures at Day 7 or the day of discharge, Day 30, and end-of-study procedures on Day 90.
Conditions
- Acute Ischemic Stroke
Interventions
QD202Drug
QD202 is a 19 amino acid peptide that consists of a 8 amino acid active domain and an 11 amino acid domain that enables the peptide to cross the blood-brain barrier.
PlaceboDrug
The placebo matches the investigational drug in appearance.
Primary outcomes
What the sponsor says the trial is designed to measure.
- Safety and ToleranceTime frame: Through study completion, an average of 90 days
Locations
14 sites in 1 country. Site status is shown where the registry gives one.
Meizhou People's Hospital
Meizhou, Guangdong, China · Recruiting
Luoyang Central Hospital
Luoyang, Henan, China · Recruiting
Nanshi Hospital of Nanyang
Nanyang, Henan, China · Recruiting
Jilin Province People's Hospital
Changchun, Jilin, China · Recruiting
Meihe Hospital the First Hospital of Jilin University
Meihekou, Jilin, China · Recruiting
Benxi Central Hospital
Benxi, Liaoning, China · Recruiting
General Hospital of Fuxin Mining Industry Group of Liaoning Health Industry Group
Fuxin, Liaoning, China · Recruiting
Central Hospital Affiliated to Shenyang Medical College
Shengyang, Liaoning, China · Recruiting
General Hospital of Northern Theater Command
Shenyang, Liaoning, China · Recruiting
Linyi People's Hospital
Linyi, Shandong, China · Recruiting
Weifang People's Hospital
Weifang, Shandong, China · Recruiting
Huashan Hospital Fudan University
Shanghai, Shanghai Municipality, China · Recruiting
Shanghai Tenth People's Hospital
Shanghai, Shanghai Municipality, China · Recruiting
Linfen Central Hospital
Linfen, Shanxi, China · Recruiting
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.